Wendy Chapman insider trades: ProNAi Therapeutics (DNAI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Wendy reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 22, 2016 | DNAI | ↓ Sell | 3,000 | $7.01 | $21K | Direct | Mar 24, 2016 (2d) |
| Feb 22, 2016 | DNAI | ↓ Sell | 3,000 | $7.06 | $21K | Direct | Feb 24, 2016 (2d) |
| Jan 22, 2016 | DNAI | ↓ Sell | 5,000 | $9.39 | $47K | Direct | Jan 25, 2016 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Wendy Chapman's insider trades
Wendy Chapman is SVP Clinical Operations at ProNAi Therapeutics (DNAI). Since Jan 22, 2016, Wendy has reported no open-market purchases and 3 sales worth $89K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (3 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.